Research News

COVID-19 Vaccine less efficient in Immunocompromised patients

This review, led by Dr Raghav Sundar and Dr Soon Yu Yang, show that covid-19 vaccines provide significantly lower protection in immunocompromised patients. It highlights the importance of a second dose of covid-19 vaccine and recommends administration of a third covid-19 vaccines dose to confer improved protection for immunocompromised patients.

 

Read more: https://doi.org/10.1136/bmj-2021-068632

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

ZBTB48: A New On-Switch for the Immune Response

CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections and cancer …

Read More →
Research News

Magnetic Field Therapy Improves Breast Cancer Treatment with Fewer Side Effects

Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire body, which, …

Read More →
Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →